Free Trial

Design Therapeutics (DSGN) SEC Filings & 10K Form

Design Therapeutics logo
$5.33 +0.17 (+3.29%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$5.32 -0.01 (-0.17%)
As of 08/15/2025 04:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Design Therapeutics SEC Filings

DateFilerForm TypeView
08/14/2025
3:15 PM
Design Therapeutics (Issuer)
William Arsani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025
7:04 PM
Design Therapeutics (Subject)
Logos Global Master Fund LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2025
7:05 PM
Design Therapeutics (Subject)
Logos Opportunities Fund II LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2025
3:30 PM
Design Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:30 PM
Design Therapeutics (Issuer)
Schmid John P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:30 PM
Berger Heather A. (Reporting)
Design Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:30 PM
Design Therapeutics (Issuer)
William Arsani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:30 PM
Design Therapeutics (Issuer)
Prasad Deepa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2025
11:15 PM
Design Therapeutics (Filer)
Form EFFECT
04/24/2025
3:13 PM
Design Therapeutics (Filer)
Form ARS
03/10/2025
6:30 AM
Design Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/10/2025
6:10 AM
Design Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
6:16 AM
Design Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/13/2025
8:09 AM
Design Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
6:00 PM
Design Therapeutics (Issuer)
Jeffries Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:00 PM
Design Therapeutics (Issuer)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:00 PM
Burgess Julie (Reporting)
Design Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:00 PM
Design Therapeutics (Issuer)
LAPPE RODNEY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:30 PM
Design Therapeutics (Issuer)
Prasad Deepa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DSGN) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners